全、新、優(yōu)、品、好四大特點：

磷酸化核糖體S6激酶RSK2抗體說明書 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細胞等，基本上各種科研所需產(chǎn)品在我司都能找到。

新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。

優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。

好：我公司具有優(yōu)質(zhì)的技術(shù)團隊，產(chǎn)品一旦售出，實驗過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。

磷酸化核糖體S6激酶RSK2抗體說明書 英文名稱  Anti-Phospho-RSK2 (Ser227)

中文名稱  磷酸化核糖體S6激酶RSK2抗體說明書 

別    名 Rsk 2; MAPKAP Kinase 1b; MAP kinase activated protein kinase 1b; MAPK activated protein kinase 1b; 90 kDa ribosomal protein S6 kinase 3; HU2; HU3; Insulin stimulated protein kinase 1; ISPK1; MAPKAPK 1b; MAPKAPK1B; MRX19; p90 RSK3; p90RSK3; pp90RSK2; Ribosomal protein S6 kinase 90kDa polypeptide 3; Ribosomal protein S6 kinase alpha 3; Ribosomal S6 kinase 2; RPS6KA3; S6 kinase 2; S6K alpha3; KS6A3_HUMAN.

產(chǎn)品屬性：

濃    度  1mg/1ml

規(guī) 格  0.1ml/100μg

抗體來源  Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit

產(chǎn)品類型   一抗 磷酸化抗體  

研究領(lǐng)域     免疫學(xué) 信號轉(zhuǎn)導(dǎo) 細胞凋亡 轉(zhuǎn)錄調(diào)節(jié)因子 激酶和磷酸酶

蛋白分子量  predicted molecular weight: 84kDa 

性    狀   Lyophilized or Liquid

免 疫 原  KLH conjugated Synthesised phosphopeptide derived from human RSK2 around the phosphorylation site of Ser227

亞    型  IgG

純化方法   affinity purified by Protein A

儲 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

磷酸化核糖體S6激酶RSK2抗體說明書 產(chǎn)品應(yīng)用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 RSK2 or MAPKAP Kinase 1b is a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains two non-identical kinase catalytic domains and phosphorylates various substrates including ribosomal protein S6 and members of the mitogen activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Mutations in this gene have been associated with Coffin Lowry syndrome.

Function : Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1. In fibroblast, is required for EGF-stimulated phosphorylation of CREB1 and histone H3 at 'Ser-10', which results in the subsequent transcriptional activation of several immediate-early genes. In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP. Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity. Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex. In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation. Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway. Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function. Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression. In LPS-stimulated dendritic cells, is involved in TLR4-induced macropinocytosis, and in myeloma cells, acts as effector of FGFR3-mediated transformation signaling, after direct phosphorylation at Tyr-529 by FGFR3. Phosphorylates DAPK1.

Subunit : Forms a complex with either MAPK1/ERK2 or MAPK3/ERK1 in quiescent cells. Transiently dissociates following mitogenic stimulation (By similarity). Interacts with NFATC4, ETV1/ER81 and FGFR1.

Subcellular Location : Nucleus. Cytoplasm.

Tissue Specificity : Expressed in many tissues, highest levels in skeletal muscle.

Post-translational modifications : Activated by phosphorylation at Ser-227 by PDPK1. Autophosphorylated on Ser-386, as part of the activation process. May be phosphorylated at Thr-365 and Ser-369 by MAPK1/ERK2 and MAPK3/ERK1. Can also be activated via phosphorylation at Ser-386 by MAPKAPK2.

N-terminal myristoylation results in an activated kinase in the absence of added growth factors.

DISEASE : Defects in RPS6KA3 are the cause of Coffin-Lowry syndrome (CLS) [MIM:303600]. A X-linked mental retardation associated with facial and digital dysmorphisms, progressive skeletal malformations, growth retardation, hearing deficit and paroxysmal movement disorders.

Defects in RPS6KA3 are the cause of mental retardation X-linked type 19 (MRX19) [MIM:300844]. MRX19 is a non-syndromic form of mild to moderate mental retardation. Mental retardation is characterized by significantly below average general intellectual functioning associated with impairments in adaptative behavior and manifested during the developmental period. In contrast to syndromic or specific X-linked mental retardation which also present with associated physical, neurological and/or psychiatric manifestations, intellectual deficiency is the only primary symptom of non-syndromic X-linked mental retardation.

Similarity : Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. S6 kinase subfamily.

Contains 1 AGC-kinase C-terminal domain.

Contains 2 protein kinase domains.

實驗流程：

正在熱銷的相關(guān)產(chǎn)品：

Nogo-B/A 軸索過度生長抑制因子-B/A抗原Multi-class antibodies規(guī)格： 0.5mg

anti-AQP1 水通道蛋白1抗體Multi-class antibodies規(guī)格： 0.1ml

Rhesus antibody Rh phospho-ATG9A(Ser735) 磷酸化自噬相關(guān)蛋白9A抗體 規(guī)格 0.1ml

山羊抗大鼠 IgM/HRP 0.1ml 美國Jackson公司分裝

VWF 英文名稱： 假性因子/性因子抗體 0.1ml

Delta Opioid Receptor 英文名稱： D型受體抗體 0.1ml

anti-AQP1 水通道蛋白1抗體Multi-class antibodies規(guī)格： 0.1ml

Anti-PS-1(CT)/FITC 熒光素標(biāo)記早老素蛋白-1抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rabbit Anti-mouse IgG-Fc Whole serum 兔抗小鼠IgG-Fc抗血清Multi-class antibodies規(guī)格： 1ml

白介素6 Anti-IL-6 Human 0.1ml

Rabbit anti-Goat IgM whole serum 兔抗羊IgM抗血清 1ml

Ferredoxin Reductase 英文名稱： 鐵氧化還原蛋白還原酶抗體 0.2ml

Rhesus antibody Rh phospho-Proteasome 20S beta 7(Ser214) 磷酸化蛋白酶體PSMβ7抗體 規(guī)格 0.2ml

Rabbit Anti-mouse IgG-Fc Whole serum 兔抗小鼠IgG-Fc抗血清Multi-class antibodies規(guī)格： 1ml

SV2C 英文名稱： 突觸泡蛋白2C抗體 0.2ml

ELL3 英文名稱： 神經(jīng)生長因子調(diào)控抑制蛋白抗體 0.2ml

染色盒同源物3抗體 Anti-CBX3 0.1ml

Anti-ULBP2/N2DL2/FITC 熒光素標(biāo)記兔抗人、大、小鼠UL16結(jié)合蛋白2抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh Phospho-Histone H3 (Ser10) 磷酸化組蛋白H3抗體 規(guī)格 0.1ml

CD10/CALLA (Neutral Endopeptidase) CD10抗原Multi-class antibodies規(guī)格： 0.5mg

RA, 大鼠星形膠質(zhì)細胞

細胞HBV病毒株

ACPP Others Human 人 ACPP / PSAP 人細胞裂解液 (陽性對照)

CL-0299NCI-H460(人細胞)5×106cells/瓶×2

人臍動脈內(nèi)皮細胞cDNAHUAEC cDNA

SV40T轉(zhuǎn)化的人胚腎細胞;293T 人卵巢微內(nèi)皮細胞完全培養(yǎng)基 100mL

CL-0156MFC(小鼠細胞)5×106cells/瓶×2

CD83 Others Cynomolgus 食蟹猴 CD83 人細胞裂解液 (陽性對照)

人*細胞裂解物HHL

UACC812細胞，人導(dǎo)管瘤細胞 鼠腹水瘤,EAC-E2G8細胞 腦動脈平滑肌細胞Many types of cells包裝：5 × 105次方(1ml)

BEL-7405(人細胞) 5×106cells/瓶×2

HPASMC Pellet 人肺動脈平滑肌細胞團塊 > 1 mio.cells 人*細胞裂解物HHL

磷酸化核糖體S6激酶RSK2抗體說明書 RA, 大鼠星形膠質(zhì)細胞

細胞HBV病毒株

ACPP Others Human 人 ACPP / PSAP 人細胞裂解液 (陽性對照)

CL-0299NCI-H460(人細胞)5×106cells/瓶×2

人臍動脈內(nèi)皮細胞cDNAHUAEC cDNA

SV40T轉(zhuǎn)化的人胚腎細胞;293T 人卵巢微內(nèi)皮細胞完全培養(yǎng)基 100mL

技術(shù)外包服務(wù):

★磷酸化核糖體S6激酶RSK2抗體說明書 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測序、載體構(gòu)建等

★蛋白工程：原核、哺乳動物蛋白表達系統(tǒng)等

★病毒包裝：腺病毒、慢病毒等

★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★細胞工程：細胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細胞培養(yǎng)、細胞膜制備、穩(wěn)定細胞株構(gòu)建、細胞RNAi技術(shù)等等。